Research Bio
Dr. Janelsins' laboratory focuses on : 1) understanding clinical, psychological, and biological mechanisms of cognitive difficulties in cancer patients 2) investigating interventions to alleviate cognitive difficulties in cancer patients, and 3) translational models of cognitive difficulties in cancer.
Dr. Janelsins' area of expertise is in psychoneuroimmunology, immunology, neuroscience, and cognitive science. In addition to a focus on cognition and cancer, her lab is broadly interested in many aspects of research related to quality of life improvement and side effect management in cancer.
| Citation Award | Society of Behavioral Medicine |
2014 |
| NIH Director's New Innovator Award | NIH |
2014 |
| NCI K07 Career Development Award | NCI |
2013 - 2018 |
| MASCC Outstanding Young Investigator of the Year Award | Multinational Association for Supportive Care in Cancer |
2013 |
| Markey Cancer Center and NCI International Conference on the Side Effects of Cancer Research Abstract Award |
2011 |
| NCI Clinical Research Loan Repayment Program Award |
2011 - Present |
| ASPO New Investigator Award |
2011 |
| Distinguished Fellow, NIH Institute on Design & Conduct of Randomized Controlled Trials Involving Behavioral Interventions | OBSSR |
2010 |
| Highest Ranked Abstract Award for the Annual Meeting of ASPO | American Society of Preventive Oncology |
2010 |
| Research Abstract Award | Society of Behavioral Medicine |
2009 |
| First Prize Poster Award | American Society for Preventive Oncology |
2009 |
| NCI Cancer Control Fellowship Award |
2008 - 2011 |
| Outstanding Abstract Award | Keystone: Alzheimer's Disease Meeting |
2006 |
| Individual National Research Service Award (NRSA) | NINDS |
2005 - 2008 |
2016 Sep
Williams AM, Zent CS, Janelsins MC. "What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research." British journal of haematology. 2016 Sep; 174(6):835-46. Epub 2016 Jul 08. |
2016 Jun 28
Janelsins MC, Heckler CE, Thompson BD, Gross RA, Opanashuk LA, Cory-Slechta DA. "A clinically relevant dose of cyclophosphamide chemotherapy impairs memory performance on the delayed spatial alternation task that is sustained over time as mice age." Neurotoxicology. 2016 Jun 28; Epub 2016 Jun 28. |
2015 Sep
Kamen C, Mustian KM, Heckler C, Janelsins MC, Peppone LJ, Mohile S, McMahon JM, Lord R, Flynn PJ, Weiss M, Spiegel D, Morrow GR. "The association between partner support and psychological distress among prostate cancer survivors in a nationwide study." Journal of cancer survivorship : research and practice. 2015 Sep; 9(3):492-9. Epub 2015 Jan 21. |
2015 Jan
Sprod LK, Fernandez ID, Janelsins MC, Peppone LJ, Atkins JN, Giguere J, Block R, Mustian KM. "Effects of yoga on cancer-related fatigue and global side-effect burden in older cancer survivors." Journal of geriatric oncology. 2015 Jan; 6(1):8-14. Epub 2014 Oct 30. |
2015
Kamen C, Blosnich JR, Lytle M, Janelsins MC, Peppone LJ, Mustian KM. "Cigarette Smoking Disparities among Sexual Minority Cancer Survivors." Preventive medicine reports. 2015 2:283-286. |
